Quick Answer
BIOLIFE SOLUTIONS INC reported Gross Profit of $62.12 million for the year ending 2025.
- BIOLIFE SOLUTIONS INC showed an increase of +24.0% in Gross Profit from 2024 to 2025.
- This data is from BIOLIFE SOLUTIONS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $193.6 thousand | Q3 2010: $224.8 thousand | Q1 2011: $242.2 thousand | Q2 2011: $333.9 thousand | Q3 2011: $370.0 thousand | Q1 2012: $489.8 thousand | Q2 2012: $455.7 thousand | Q3 2012: $595.4 thousand | Q1 2013: $1.13 million | Q2 2013: $828.4 thousand | Q3 2013: $888.9 thousand | Q1 2014: $903.4 thousand | Q2 2014: $545.3 thousand | Q3 2014: $588.4 thousand | Q1 2015: $882.6 thousand | Q2 2015: $818.6 thousand | Q3 2015: $973.4 thousand | Q1 2016: $1.08 million | Q2 2016: $1.12 million | Q3 2016: $1.21 million | Q1 2017: $1.44 million | Q2 2017: $1.60 million | Q3 2017: $1.87 million | Q1 2018: $2.45 million | Q2 2018: $3.64 million | Q3 2018: $3.69 million | Q1 2019: $4.12 million | Q2 2019: $4.74 million | Q3 2019: $4.52 million.
- Over the full 12 years of available data (2010 to 2025), BIOLIFE SOLUTIONS INC's Gross Profit has grown by 7,153.5%.
- Historical annual values: Fiscal year 2025: $62.12 million | Fiscal year 2024: $50.10 million | Fiscal year 2023: $41.32 million | Fiscal year 2018: $13.53 million | Fiscal year 2017: $6.75 million | Fiscal year 2016: $4.78 million | Fiscal year 2015: $3.81 million | Fiscal year 2014: $3.04 million | Fiscal year 2013: $3.76 million | Fiscal year 2012: $2.29 million | Fiscal year 2011: $1.40 million | Fiscal year 2010: $856.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: